IOVA 240913 9.50C (IOVA240913C9500) Stock Options, News & Quotes

0.85
+0.70+466.67%

15min DelayClose Sep 13 16:00 ET

0.90High0.20Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

EZ_money

Sep 4 06:54

$Psyence Biomedical (PBM.US)$👈 good news out 🤑🥳🎈🎉
$Sunshine Biopharma (SBFM.US)$ $Iovance Biotherapeutics (IOVA.US)$

BelleWeather

Sep 3 07:24

Iovance

I am continuing to hold this position, but no longer adding to it as I simply am overexposed to this space. Upon reexamination, I’m neutral to hopeful this will be a solid longterm hold. (Though also a candidate to sell should another opportunity present itself.)

Share Your Profit/Loss

EZ_money

Aug 26 10:47

$Emergent BioSolutions (EBS.US)$ 👀could it be .... possible comeback? EBS is one of three companies ready to deploy mpox vaccines. With that said, you look at institutions owning this and you have the two largest with BlackRock and Vanguard..... plus Charles Schwab is no tiny outfit. $Iovance Biotherapeutics (IOVA.US)$ $Redhill Biopharma (RDHL.US)$

Trytosaveabit

Aug 21 14:02

Hey thanks Martin! Hehehe

$Iovance Biotherapeutics (IOVA.US)$ Martin Shkreli Post On X, "$IOVA Pretty Attractive Long Idea"

EZ_money

Aug 21 08:25

$GeoVax Labs (GOVX.US)$ 👀 🥳 Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for Control, Treatment, and Prevention
ATLANTA, GA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- GeoVax Lab, Inc. (Nasdaq: GOVX) ("GeoVax Labs" or the "Company"), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that David Dodd, CEO of GeoVax Labs, will present at Tribe Public's Webinar Presentation and Q&A Ev...